Back to Results
First PageMeta Content
Immunosuppressants / Biotechnology / Norwalk / Connecticut / Multiple myeloma / Bortezomib / International Myeloma Foundation / University of Arkansas for Medical Sciences / Lenalidomide / Multiple Myeloma Research Foundation / Medicine / Cancer organizations / Cancer research


A PUBLICATION OF THE UAMS MYELOMA INSTITUTE FOR RESEARCH AND THERAPY SUMMER 2014 Dr. Gareth Morgan Takes Helm at Myeloma Institute as different as one fingerprint is
Add to Reading List

Document Date: 2014-08-06 12:47:43

Open Document

File Size: 565,69 KB

Share Result on Facebook

City

San Antonio / Little Rock / New Orleans / London / /

Company

Facebook / Janssen Biotech Inc. / Takeda Pharmaceuticals Company / General Improvement Funds / Myeloma UK / /

Continent

Europe / /

Country

United Kingdom / United States / /

Currency

USD / /

/

Event

FDA Phase / Person Travel / /

Facility

University of Leeds / UAMS Myeloma Institute / Dana Farber Cancer Institute / Winthrop P. Rockefeller Cancer Institute / The Institute of Cancer Research / University of London / Myeloma Institute / Institute of Cancer Research / Royal Marsden Hospital / /

IndustryTerm

Treatment for Castleman’s Disease / bank / gas card / earlier applications / liquid nitrogen tissue bank / treatment of relapsed refractory disease / /

MedicalCondition

individuals’ myeloma cancer / refractory disease / ovarian cancer / multiple myeloma / biopsy-proven systemic light chain amyloidosis / largest comprehensive cancer / Amyloid Light-chain Amyloidosis / leukemia / Castelman’s Disease / cancer / HIV-negative Castleman’s Disease / low-risk disease / rare lymph node disorder / Multicentric Castleman’s Disease / resistant tumor / highrisk disease / relapsed refractory disease / Infections / Refractory Systemic Light Chain Amyloidosis / Castleman’s Disease / rare blood disorder / disease / high-risk disease / chronic and debilitating disease / malignant lymphoma / prolonged thrombocytopenia / /

MedicalTreatment

molecular therapeutics / chemotherapy / /

Organization

Cancer Center / Myeloma Institute / University of Leeds / Speer Patient Support Fund / British Society of Haematology / Advisory Board / UAMS Myeloma Institute / Myeloma UK Research Centre / Myeloma Institute Development Division / European Commission / Myeloma Institute for Research and Therapy / FDA / International Myeloma Foundation / Leading Clinician-Scientist Joins Myeloma Institute Faculty / NHS / the Ohio State University / University of London / UAMS Center for Patients and Families / Cancer Research and Royal Marsden Hospital in London / UAMS Auxiliary / Dana Farber Cancer Institute in Boston / Scientific Board / UAMS MYELOMA INSTITUTE FOR RESEARCH AND THERAPY SUMMER / Centre for Myeloma Research / Enter Patient Support Fund / Institute of Cancer Research in London / Winthrop P. Rockefeller Cancer Institute / Welsh National School of Medicine / /

Person

Jimmy Moses Little Rock / Eunice Galsky / Michael Birnbaum San Antonio / Ilana / Stephen Engstrom Little Rock / Laurie Shell / Donald Yanick Wilmington / Frits van Rhee / Bart Barlogie / Lucia Dougherty Miami / Mike Beebe / Amanda Smith / Denny Holman Dallas / Gladys Monroy Palo Alto / Bob Kohler Fayetteville / Richard / Louis Cella St. Louis / Gareth Morgan / Faith Davies / Joseph Walker Dana / Carl Guenther / Stuart Cobb Little Rock / William Webb Nashville / Susan Speer / Carol Ammon / Adam / Janet Aronson / Denis McDonald / Alan Galsky / /

/

Position

director of Myeloma UK / Physician / rt / leader in the research / scientific coordinator / http /

Product

Velcade / Dexamethasone / TT5B / Multicenter Study Comparing Oral / Dexamethasone Plus / Dexamethasone Plus Oral / FDA-approved drug / /

ProvinceOrState

Ohio / Louisiana / Hawaii / Texas / Delaware / Arkansas / /

PublishedMedium

Cancer Research / /

Technology

drug discovery / Therapy protocol / Gene Expression / chemotherapy / successive TT protocols / av / transplantation / Therapy protocols / /

URL

http /

SocialTag